Equivalent medicines free-up resources
Equivalent medicines fulfil a social role, providing low-cost, high-quality medicines. The economic resources freed-up through savings on pharmaceutical products can be used to acknowledge the high costs of research borne by the pharmaceutical companies.
In Italy, however, the move from original medicines to equivalent ones is happening more slowly than in other countries, due in part to their delay in entering the welfare system. The culture of equivalent medicines has yet to become widespread among physicians, pharmacists and patients.